ArticleCancers2023

Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia.

Anna Guarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.